celecoxib has been researched along with Syndrome in 10 studies
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the effectiveness of celecoxib in reducing symptoms in patients with difficult chronic pelvic pain syndrome (CPPS), NIH category IIIA." | 9.14 | Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA). ( Ding, GQ; Li, GH; Li, XD; Rui, XF; Yu, D; Zhang, ZG; Zhao, WP, 2009) |
| "The Fernand Widal syndrome is a set of associations between asthma, nasal polyposis and aspirin sensitivity." | 7.88 | [Is celecoxib a safe alternative for the Fernand Widal syndrome?] ( De Blay, F; Guenard-Bilbaut, L; Metz-Favre, C; Schaller, A, 2018) |
| " We undertook a retrospective study comparing the incidences of hand-foot syndrome in 67 patients with metastatic colorectal cancer who took capecitabine (Xeloda) with or without celecoxib." | 7.71 | Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity. ( Ayers, GD; Lin, E; Morris, JS, 2002) |
| "We investigated the effectiveness of celecoxib in reducing symptoms in patients with difficult chronic pelvic pain syndrome (CPPS), NIH category IIIA." | 5.14 | Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA). ( Ding, GQ; Li, GH; Li, XD; Rui, XF; Yu, D; Zhang, ZG; Zhao, WP, 2009) |
| "The Fernand Widal syndrome is a set of associations between asthma, nasal polyposis and aspirin sensitivity." | 3.88 | [Is celecoxib a safe alternative for the Fernand Widal syndrome?] ( De Blay, F; Guenard-Bilbaut, L; Metz-Favre, C; Schaller, A, 2018) |
| " We undertook a retrospective study comparing the incidences of hand-foot syndrome in 67 patients with metastatic colorectal cancer who took capecitabine (Xeloda) with or without celecoxib." | 3.71 | Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity. ( Ayers, GD; Lin, E; Morris, JS, 2002) |
| "Kaposiform hemangioendothelioma is a rare vascular tumor of childhood that is locally aggressive but has little metastatic potential and by itself is not known to be lethal." | 1.35 | Kaposiform hemangioendothelioma in multiple spinal levels without skin changes. ( Bradeen, HA; Kalof, AN; Lisle, JW, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schaller, A | 1 |
| Metz-Favre, C | 1 |
| Guenard-Bilbaut, L | 1 |
| De Blay, F | 1 |
| Danilov, AB | 1 |
| Grigorenko, NV | 1 |
| Lee, JH | 1 |
| Park, HK | 1 |
| Heo, J | 1 |
| Kim, TO | 1 |
| Kim, GH | 1 |
| Kang, DH | 1 |
| Song, GA | 1 |
| Cho, M | 1 |
| Kim, DS | 1 |
| Kim, HW | 1 |
| Lee, CH | 1 |
| Ilizaliturri, VM | 1 |
| Chaidez, C | 1 |
| Villegas, P | 1 |
| Briseño, A | 1 |
| Camacho-Galindo, J | 1 |
| Lisle, JW | 1 |
| Bradeen, HA | 1 |
| Kalof, AN | 1 |
| Zhao, WP | 1 |
| Zhang, ZG | 1 |
| Li, XD | 1 |
| Yu, D | 1 |
| Rui, XF | 1 |
| Li, GH | 1 |
| Ding, GQ | 1 |
| Beck, PL | 1 |
| Aspinall, AI | 1 |
| Kilvert, VM | 1 |
| Dort, J | 1 |
| Lin, E | 1 |
| Morris, JS | 1 |
| Ayers, GD | 1 |
| Cerchietti, LC | 2 |
| Navigante, AH | 2 |
| Peluffo, GD | 1 |
| Diament, MJ | 1 |
| Stillitani, I | 1 |
| Klein, SA | 1 |
| Cabalar, ME | 1 |
| Castro, MA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine: A Randomized Controlled Trial.[NCT05641246] | Phase 2 | 66 participants (Anticipated) | Interventional | 2022-12-08 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for celecoxib and Syndrome
| Article | Year |
|---|---|
[An antinociceptive effect of chondroprotectors: a myth or a reality?].
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Celecoxib; Chondroitin Sulf | 2015 |
4 trials available for celecoxib and Syndrome
| Article | Year |
|---|---|
Prospective randomized study of 2 different techniques for endoscopic iliopsoas tendon release in the treatment of internal snapping hip syndrome.
Topics: Adult; Arthroscopy; Celecoxib; Combined Modality Therapy; Female; Hip Joint; Humans; Joint Capsule; | 2009 |
Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA).
Topics: Adolescent; Adult; Celecoxib; Chronic Disease; Cyclooxygenase 2 Inhibitors; Humans; Male; Middle Age | 2009 |
Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: a pilot study.
Topics: Adenocarcinoma; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cachexi | 2004 |
Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Appetite; C-Reactive Protein; Cachexia; Celecoxib; Cohort Studies; C | 2007 |
5 other studies available for celecoxib and Syndrome
| Article | Year |
|---|---|
[Is celecoxib a safe alternative for the Fernand Widal syndrome?]
Topics: Adult; Aged; Aspirin; Asthma; Case-Control Studies; Celecoxib; Drug Hypersensitivity; Female; France | 2018 |
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Arthritis; Celecoxib; Drug Er | 2008 |
Kaposiform hemangioendothelioma in multiple spinal levels without skin changes.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers, Tumor; Celecoxib; Chil | 2009 |
Blue rubber bleb nevus syndrome.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Colonic Diseases; Gastrointestina | 2002 |
Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Capecitabine; Celecoxib; Colorectal Neoplasms; | 2002 |